SEC FILING

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 14, 2011

Accession Number

0000902219-11-000907

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →